Szerző: " Margeli Mireia"

Agrawal Yash N; Fernandez-Martinez Aranzazu; Gil-Gil Miguel; Zielinski Christoph; Ruiz-Borrego Manuel; Ciruelos Eva Maria; Munoz Montserrat; Margeli Mireia; Bermejo Begona; Anton Antonio; Kahán Zsuzsanna; Csöszi Tibor; Alonso-Romero Jose Luis; Garcia-Saenz Jose Angel; Sanchez-Rovira Pedro; Alvarez Elena; Chacon Jose Ignacio; Gonzalez-Santiago Santiago; Rodriguez Cesar A; Servitja Sonia; Pfefferle Adam D; Herranz Jesus; Liu Yuan; Carey Lisa A; Romero-Camarero Isabel; Caballero Rosalia; Guerrero-Zotano Angel; Perou Charles M; Martin Miguel: Transcriptomic Predictors of Survival for Palbociclib + Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor-Resistant Breast Cancer From the GEICAM/2013-02 PEARL Trial.
JCO PRECISION ONCOLOGY, 9. ISSN 2473-4284 (2025)

Martin Miguel; Zielinski Christoph; Ruiz-Borrego Manuel; Carrasco Eva; Ciruelos Eva M.; Munoz Montserrat; Bermejo Begona; Margeli Mireia; Csoszi Tibor; Anton Antonio; Turner Nicholas; Casas Maria I; Morales Serafin; Alba Emilio; Calvo Lourdes; De La Haba-Rodriguez Juan; Ramos Manuel; Murillo Laura; Santaballa Ana; Alonso-Romero Jose L.; Sanchez-Rovira Pedro; Corsaro Massimo; Huang Xin; Thallinger Christiane; Kahán Zsuzsanna; Gil-Gil Miguel: Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study.
EUROPEAN JOURNAL OF CANCER, 168. pp. 12-24. ISSN 0959-8049 (2022)

Kahán Zsuzsanna; Gil-Gil Miguel; Ruiz-Borrego Manuel; Carrasco Eva; Ciruelos Eva; Muñoz Montserrat; Bermejo Begoña; Margeli Mireia; Antón Antonio; Casas Maribel; Csöszi Tibor; Murillo Laura; Morales Serafín; Calvo Lourdes; Láng István: Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor–positive metastatic breast cancer: Patient-reported outcomes in the PEARL study.
EUROPEAN JOURNAL OF CANCER, 156. pp. 70-82. ISSN 0959-8049 (2021)